Methods for reducing or eliminating the need for lipoprotein apheresis in patients with… Grant US-11904017-B2 United States of America 20 Feb 2024
Stabilized formulations containing anti-PCSK9 antibodies Grant US-11673967-B2 United States of America 13 Jun 2023
Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with… Grant US-11306155-B2 United States of America 19 Apr 2022
Human antibodies to PCSK9 for use in methods of treating particular groups of subjects Grant US-11246925-B2 United States of America 15 Feb 2022
Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with… Grant US-10544232-B2 United States of America 28 Jan 2020
Dosing regimens for use with PCSK9 inhibitors Grant US-10428157-B2 United States of America 01 Oct 2019
Pharmaceutical compositions comprising human antibodies to PCSK9 Grant US-9682013-B2 United States of America 20 Jun 2017
Method of reducing cholesterol levels using a human anti-PCSK9 antibody Grant US-9561155-B2 United States of America 07 Feb 2017
METHODS FOR TREATING AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA ASSOCIATED WITH PCSK9 GAIN-OF… Application WO-2014194111-A1 World Intellectual Property Organisation (WIPO) 04 Dec 2014